|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 14-09-16 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 14-09-04 | Roche : rules out mega deals, open to smaller ones - paper | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 2002-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 2011-07-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.14% | -1.16% | -11.90% | -10.16% | 43.51B | ||
| -2.17% | +4.70% | +293.71% | +535.99% | 33.29B | ||
| -1.60% | -1.58% | -0.19% | +31.82% | 29.34B | ||
| +0.44% | -3.80% | +12.51% | -17.06% | 29.9B | ||
| -0.29% | +2.65% | +13.24% | +21.04% | 25.42B | ||
| +3.54% | +8.43% | - | - | 14.36B | ||
| -1.26% | -1.11% | +53.37% | +108.10% | 13.18B | ||
| -1.15% | -5.17% | +2.31% | +3.40% | 12.72B | ||
| -1.18% | -2.00% | +107.41% | +78.18% | 12.08B | ||
| Average | -0.41% | +0.59% | +58.81% | +93.91% | 23.76B | |
| Weighted average by Cap. | -0.53% | +0.64% | +60.14% | +104.15% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
















